Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technologyKeman Cheng, Guangjun Nie, Jie Liang et al.|Nature Communications|2021Cited by 449
Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer ImmunotherapyKeman Cheng, Guangjun Nie, Yanping Ding et al.|Nano Letters|2018Cited by 322
Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy <i>via</i> Immune Activation and Checkpoint InhibitionYao Li, Guangjun Nie, Ruifang Zhao et al.|ACS Nano|2020Cited by 271
Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-DioxygenaseXuexiang Han, Yiye Li, Keman Cheng et al.|Journal of the American Chemical Society|2020Cited by 131
Anti-lymphangiogenesis for boosting drug accumulation in tumorsChunling Wang, Yinlong Zhang|Signal Transduction and Targeted Therapy|2024Cited by 14